Cigna Group Quarterly Income Tax Expense (Benefit) in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Cigna Group quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2018 to Q3 2024.
  • Cigna Group Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $367M, a 6.14% decline year-over-year.
  • Cigna Group Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $99M, a 91.7% decline year-over-year.
  • Cigna Group annual Income Tax Expense (Benefit) for 2023 was $141M, a 91.3% decline from 2022.
  • Cigna Group annual Income Tax Expense (Benefit) for 2022 was $1.62B, a 17.9% increase from 2021.
  • Cigna Group annual Income Tax Expense (Benefit) for 2021 was $1.37B, a 42.4% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $99M $367M -$24M -6.14% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $123M $360M -$14M -3.74% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $137M $291M -$4M -1.36% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $141M -$919M -$1.06B -776% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $1.2B $391M -$322M -45.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $1.52B $374M -$37M -9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $1.56B $295M -$60M -16.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $1.62B $136M -$46M -25.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $1.66B $713M +$289M +68.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $1.37B $411M -$11M -2.61% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $1.38B $355M +$13M +3.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $1.37B $182M -$1.05B -85.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $2.42B $424M +$18M +4.43% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $2.41B $422M -$107M -20.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $2.51B $342M +$134M +64.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $2.38B $1.24B +$959M +346% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $1.42B $406M -$3M -0.73% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $1.42B $529M +$181M +52% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $1.24B $208M -$208M -50% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $1.45B $277M +$196M +242% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $1.25B $409M +$150M +57.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $1.1B $348M +$54M +18.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $1.05B $416M +$115M +38.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $935M $81M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $259M Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $294M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $301M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.